Aditya Birla Sunlife Life Pharma and Healthcare Fund Normal IDCW Payout
Aditya Birla Sun Life AMC Ltd
₹22.88 (-0.04%)
NAV as of 12 Oct 2026
Minimum Investment: ₹1,000
Return
10.61% Returns for 1Y
Expense ratio & Others
- Net expense ratio
- 2.30%
- Exit load
- 0%
- Lock-in
- No
- Minimum investment
- ₹1,000
- Category
- Sector - Healthcare
Expense ratio is inclusive of GST. Returns may be taxed based on the fund type and your holding period — please read the scheme-related documents and consult a tax advisor. Figures are historical and do not guarantee future results.
Fund Returns Estimator
One-time investment
₹1,000
6 months
₹1,134
Invested ₹1,000
▲+13.44%1 year
₹1,106
Invested ₹1,000
▲+10.61%3 years
₹1,177
Invested ₹1,000
▲+17.67%5 years
₹1,115
Invested ₹1,000
▲+11.49%
Based on the fund’s historic trailing returns — a planning illustration, not a guarantee of future results.
Invest One-TimePlan it your way
The figures above are fixed to this fund’s past returns over set periods. Use a calculator to set your own amount, tenure and expected rate of return.
Risk level
Riskometer scale
- Low
- Low to Moderate
- Moderate
- Moderate to High
- High
- Very HighThis fund
Riskometer level assigned by the fund house as per SEBI norms. It can change as the scheme’s portfolio changes.
Fund benchmark
| Primary Index Name | BSE Healthcare PR INR |
|---|---|
| Secondary Index Name | BSE Healthcare PR |
| Index Name | BSE Healthcare TR INR |
| Weighting | 100% |
Returns
| 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|
| Fund returns (%) | +10.61% | +17.67% | +11.49% | — |
| Cumulative returns (%) | +10.61% | +62.91% | +72.27% | — |
Fund Manager
| Manager | Dhaval Shah |
|---|---|
| Role | Manager |
| Manager Tenure | 7.23 yrs |
About Fund
| Date of Incorporation | 11 Jul 2019 |
|---|---|
| Fund House | Aditya Birla Sun Life AMC Ltd |
| Custodian | Citibank NA |
| Registrar / Transfer Agent | Aditya Birla Sun Life AMC Ltd |
| Address | Citibank, N.A.,388 Greenwich Street,New York, NY 10048,USA |
Top Holdings
| Company | Weightage (%) |
|---|---|
| Torrent Pharmaceuticals Ltd | 9.28% |
| Sun Pharmaceuticals Industries Ltd | 8.61% |
| Apollo Hospitals Enterprise Ltd | 6.44% |
| Cipla Ltd | 6.38% |
| J.B. Chemicals & Pharmaceuticals Ltd | 4.71% |
| Aurobindo Pharma Ltd | 4.52% |
| Sai Life Sciences Ltd | 4.49% |
| Ajanta Pharma Ltd | 4.35% |
| Ipca Laboratories Ltd | 4.11% |
| Mankind Pharma Ltd | 3.62% |
| Dr. Lal PathLabs Ltd | 3.51% |
| Fortis Healthcare Ltd | 3.31% |
| Abbott India Ltd | 3.26% |
| Anthem Biosciences Ltd | 3.22% |
| Lupin Ltd | 3.10% |
Investment Strategy
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
Long term capital growth
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. The data shown is for information only and does not constitute investment advice.